|
What Invokana’s Day at the FDA Means for the Future of SGLT-2sWhat’s an SGLT-2 inhibitor and how does it work? Includes cool FAQ! |
January 31, 2013 |
51 |
|
|
Why Drug Names MatterWhy did Qnexa become Qsymia? diaTribe investigates the thinking behind drug names… and why they’re vital to patient safety. |
December 31, 2012 |
50 |
|
|
Avoiding Complications of DiabetesWhy does diabetes cause different health complications? How can they be avoided and how can we address them? |
February 29, 2012 |
40 |
|
|
Bringing an Artificial Pancreas to MarketWhat will it take to get an artificial pancreas approved? It seems that the path ahead may now be a bit clearer… |
January 31, 2012 |
39 |
|
|
Hard to Lose Weight, Harder to Keep it Off – A Remarkable New Study Explains WhydiaTribe's take on the recent New England Journal of Medicine's piece on weight gain - and loss! |
December 1, 2011 |
38 |
|
|
Targeting A Cure For Type 1 Diabetes – A Sneak PeekWhere are we today in the quest for a cure? |
July 5, 2011 |
34 |
|
|
The FDA Declines to Approve Bydureon, a New Once-Weekly GLP-1 AgonistThe FDA’s decision on Bydureon was a shocker. We break down this decision and discuss why we view it as such a disappointment. |
October 31, 2010 |
26 |
|
|
Decoding The ADA Scientific SessionsExciting findings from the largest diabetes meeting of the year, the American Diabetes Association’s annual Scientific Sessions. |
August 31, 2010 |
24 |
|
|
Decoding the FDA’s Perspective on Diabetes DevicesDecoding the evolving FDA perspective on diabetes devices (and how accurate is your meter, anyway?!). |
April 30, 2010 |
22 |
|
|
Metformin: Moonlighting as a Preventative Cancer TreatmentMetformin moonlights as a preventative cancer treatment. |
February 28, 2010 |
20 |
|
|
Blood Pressure 101We round out the Diabetes ABC’s with Blood Pressure 101. |
December 31, 2009 |
19 |
|
|
Cholesterol 101LDL? HDL? Recommended guidelines? We tackle cholesterol as Kelly starts a statin. |
October 31, 2009 |
18 |
|